What does Google Patents US20220183242A1 cover about vinblastine and vindoline?
US20220183242A1 is a Google Patents application record that centers on inventions involving vinblastine and vindoline, two related indole alkaloids commonly linked through the same plant-derived biosynthetic pathway (notably from Catharanthus species). The patent record will describe the specific technical approach—such as methods of producing, extracting, purifying, enriching, or otherwise using vinblastine/vindoline or related intermediates—along with claims that define the protected scope. [1]
How do vinblastine and vindoline relate in these patent filings?
Vinblastine and vindoline are closely connected because vindoline is a downstream precursor component that can be combined with other pathway-derived elements to form vinblastine (depending on the specific biosynthetic route described). Patent documents that focus on both often target steps that improve yield, control conversion between intermediates, or enable scalable manufacturing of one or both alkaloids. [1]
What claims should you look for in US20220183242A1?
To understand the real “business end” of the filing, focus on the independent claims (usually near the front of the published application). They typically specify one of the following:
- a composition claim (what the material/product is)
- a method claim (what steps are performed and in what order)
- a process/production claim (how the alkaloids are generated or processed)
- a use claim (how vinblastine/vindoline are used, for example in pharmaceutical contexts)
Those claim elements usually determine whether the invention covers an extraction workflow, a biocatalytic or enzymatic conversion workflow, purification, formulation, or a defined intermediate product. [1]
Are there competitors or alternative approaches to vinblastine/vindoline patents?
Vinblastine production and vindoline production are frequently covered across multiple patent families, often by different strategies (plant cell culture, engineered biosynthesis, enzymatic conversion, or extraction/purification improvements). Even if US20220183242A1 is specific to one approach, later or parallel patents may claim different steps or different pathway enzymes/intermediates, which can create “overlap-by-step” competition rather than a single head-to-head product claim. [1]
Where can you read the full text and claims?
On Google Patents, the published application page for US20220183242A1 includes the full bibliographic record, the published claims, and the description text. The exact wording of the claims is the most reliable way to determine what the filing actually protects about vinblastine and vindoline. [1]
Sources
- https://patents.google.com/patent/US20220183242A1/en